Skip to main content
AVACTA GROUP PLC logo

AVACTA GROUP PLC — Investor Relations & Filings

Ticker · AVCT ISIN · GB00BYYW9G87 LEI · 2138009U3EG31OPMGH36 IL Manufacturing
Open in API
Filings indexed 708 across all filing types
Latest filing 2020-04-22 M&A Activity
Country GB United Kingdom
Listing IL AVCT

About AVACTA GROUP PLC

https://avacta.com/

Avacta Group PLC is a clinical-stage biotechnology company developing targeted oncology drugs. The company's core technology is the proprietary pre|CISION® platform, a drug delivery system designed to improve the safety and efficacy of potent cancer therapies. The platform works by linking a peptide to a cancer drug, rendering it inactive in the bloodstream. The drug is precisely activated only within the tumor microenvironment by the Fibroblast Activation Protein (FAP) enzyme, which is abundant in many solid tumors. This approach aims to concentrate the active therapy at the tumor site, thereby reducing systemic toxicity and improving the therapeutic window for patients. The company is advancing a pipeline of peptide drug conjugates (PDCs) based on this platform.

Recent filings

Filing Released Lang Actions
Avacta/Cytiva Partnership Ahead of Schedule
M&A Activity Classification · 99% confidence The document begins with 'RNS Number : 4143K' and is dated April 22, 2020. It contains an announcement regarding a partnership update ('Avacta/Cytiva Partnership Ahead of Schedule') and includes a statement that 'THE INFORMATION COMMUNICATED IN THIS ANNOUNCEMENT IS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 596/2014.' The document concludes with contact information and a footer referencing 'RNS, the news service of the London Stock Exchange.' This structure strongly indicates a general regulatory news service announcement, which aligns best with the 'Regulatory Filings' (RNS) category, as it is not a specific financial report (like 10-K or IR), a management change (MANG), or a dividend notice (DIV). It is a general market update disseminated via the RNS system.
2020-04-22 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1375 characters) and contains an 'RNS Number' header, indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Second Price Monitoring Extension' and an 'auction call period extension' due to unusual price movement. This type of immediate, short-form market operational update does not fit the definitions for financial reports (10-K, IR, ER), management changes (MANG), or specific corporate actions (DIV, CAP). Since it is a general regulatory announcement that doesn't fit a more specific category like DIRS or DLST, the most appropriate classification is the general regulatory filing fallback category, RNS.
2020-04-20 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1358 characters) and contains the header "RNS Number : 1766K". It announces a specific, non-financial operational event: a "Price Monitoring Extension" for an auction call period on the London Stock Exchange. It explicitly states, "This information is provided by RNS, the news service of the London Stock Exchange." This strongly indicates it is a general regulatory announcement that does not fit into the specific financial report categories (like 10-K, ER, IR, etc.). Therefore, the most appropriate classification is the general regulatory filing fallback category.
2020-04-20 English
Notice of Results - Update
Report Publication Announcement Classification · 99% confidence The document begins with an 'RNS Number' and is explicitly identified as information provided by 'RNS, the news service of the London Stock Exchange.' The content announces a change in the timing for the announcement of financial results (for the 17 months ended 31 December 2019) and the associated analyst/shareholder webcast/Q&A session. This is a general regulatory announcement regarding scheduling updates, not the full financial report (10-K or IR) itself, nor is it a specific notice like a dividend (DIV) or director dealing (DIRS). Since it is a general regulatory announcement distributed via RNS that doesn't fit a more specific category, the appropriate classification is Regulatory Filings (RNS). The document length is moderate, but the content is purely an announcement about future events/reports.
2020-04-17 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1375 characters) and contains the header "RNS Number : 9429J". It announces a 'Second Price Monitoring Extension' related to trading activity, which is a specific, non-standard regulatory event notification. Since it is a brief announcement of a market mechanism event and does not fit into the specific categories like ER, 10-K, or DIV, the most appropriate classification is the general regulatory announcement fallback category, RNS (Regulatory Filings).
2020-04-16 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1358 characters) and begins with an 'RNS Number' and the issuer name, Avacta Group PLC. The content discusses a 'Price Monitoring Extension' related to trading on the London Stock Exchange and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure is characteristic of a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the more specific categories (like DIRS, DIV, or DLST), the appropriate fallback category is Regulatory Filings (RNS).
2020-04-16 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.